As healthcare providers we need to commit to starting treatment of #hepc and share the optimism of curing #hepc! Important work from Shashi Kapadia Weill Cornell Medicine Population Health Sciences

Eliminating Hepatitis C will be harder then we originally thought but there are solutions and possibilities, we need to continue to do research and get hard evidence on what works and not INHSU #gettingcracking

Just the best about INHSU . #INHSU2022 Engagement in all aspects from people with lived experience. It is health not “just” hepatitis.

There is no hard to reach patients- only hard to reach healthcare! #inhsu2022 INHSU

Great morning session INHSU and we are ready for the last day of inspiration! #INHSU2022

Great poster from Ben Eckhardt NYU Langone Health demonstrating fantastic #HCV treatment outcomes for young people who inject drugs (ST&RT study) #INHSU2022

Take home message from Kristian Malme today INHSU: Although HCV treatment uptake increased among people who inject drugs in 🇳🇴, strategies to improve treatment among women and individuals not engaged in OAT should be addressed!

People who use drugs cured of #hepc still has considerably higher mortality compared to the overall population! More knowledge is needed asap. @SofiaRB_88 INHSU

Thank you @SofiaRB_88 for your words! INHSU

Last session INHSU and grateful that the main result from Opportuni-C was highlighted in Tommy Brothers rapporteur! Håvard Midgard

Poster at INHSU from Maja Skaland highlighting that hospitalization is a great opportunity to test for hepatitis c! Awareness campaign improved test uptake, and we need to continue to inform and educate! #endhepc #eliminatehepc #INHSU22

New study Addiction Journal finds incarcerated people had a massive (500%) reduction in overdose deaths in the 2 months post-release when receiving jail-based MOUD. Offering this life-saving treatment should be mandatory for jails and prisons nationally.

Don’t put off until tomorrow what you can do today: Hospital admissions as an opportunity to treat hepatitis C ✅ Just Accepted 💬 Editorial Commentary 🔗 bit.ly/47nNWip

Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial academic.oup.com/cid/article/do…

Remarkable RCT from Norway demonstrating that starting HCV treatment in the hospital with newly diagnosed HCV among PWIDs is superior to deferring therapy to outpatient care in achieving HCV cure. Results argue for broader use. Håvard Midgard SELIHEP doi.org/10.1093/cid/ci…

Of course starting these critical meds in the hospital is superior, people often fall thru the cracks. Too bad US Hospitals don’t like to administer expensive drugs during hospitalization.

Inspiring work by inspiring people Ane-Kristine Håvard Midgard SELIHEP - It's time to stop writing "hcv, defer to outpatient" in your consult notes, #idtwitter

People don’t achieve HCV cure if they don’t start treatment. The implementation gap addressed just today in The New York Times by Dr Collins nytimes.com/2023/11/28/opi…

HCV TREATMENT: Start the Hepatitis C treatment while a patient is in the hospital (we do this and continue the whole time if PWID are being given 6 weeks of IV antibiotics for instance for osteomyelitis/endocarditis) - don't wait until outpatient setting. Like ART - start right

Loved starting two patients on Mavyret inpatient last week! They were so excited to get started on treatment.